Stay updated on Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the study page, expanding contextual links and resources.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded a new revision label 'Revision: v3.5.4'. Removed the core disease term 'Multiple myeloma' and related topics such as 'MedlinePlus Genetics', as well as the previous revision label 'Revision: v3.5.3'.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe study record’s results section was updated to show newly posted study results (dated 2026-04-23) and corresponding changes to multiple outcome measures. These include efficacy endpoints like complete response by IMWG, MRD negativity, progression/death and PFS measures, time to next treatment, response to first subsequent treatment, symptomatic progression with adverse prognostic features, and overall survival definitions/figures.SummaryDifference2%

- Check48 days agoChange DetectedAdded Multiple myeloma as a topic and related topics (MedlinePlus Genetics). Updated page revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check55 days agoChange DetectedRemoved the 'Multiple myeloma' topic and related 'MedlinePlus Genetics' content from the page. This reduces the disease-specific context available to users researching the study.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the page.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.